BioCentury
ARTICLE | Clinical News

HS-410: Additional Ph I/II data

January 6, 2017 9:37 PM UTC

Data from 94 patients with intermediate- or high-risk non-muscle invasive bladder cancer who have undergone transurethral resection of bladder tumor in the Phase II portion of a double-blind, U.S. Pha...